Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Cencora, Inc.
Cencora, Inc. News
Cencora, Inc. Quantitative Score

About Cencora, Inc.
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Cencora, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Cencora, Inc. Financials
Table Compare
Compare COR metrics with: | |||
---|---|---|---|
Earnings & Growth | COR | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | COR | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | COR | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | COR | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Cencora, Inc. Income
Cencora, Inc. Balance Sheet
Cencora, Inc. Cash Flow
Cencora, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Strong Buy |
Return on Equity | Strong Buy |
Return on Assets | Buy |
Debt/Equity Ratio | Strong Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Cencora, Inc. Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 2.2000 |
Payment Date | Dividend | Frequency |
---|---|---|
2025-09-03 | 0.55 | Quarterly |
2025-06-02 | 0.55 | Quarterly |
2025-03-03 | 0.55 | Quarterly |
2024-11-29 | 0.55 | Quarterly |
2024-08-26 | 0.51 | Quarterly |
Historical Market Cap
Shares Outstanding
Cencora, Inc. Executives
Name | Role |
---|---|
Mr. Steven H. Collis | Executive Chairman |
Dr. Robert P. Mauch Ph.D., PharmD | President, Chief Executive Officer & Director |
Mr. James F. Cleary Jr. | Executive Vice President & Chief Financial Officer |
Ms. Elizabeth S. Campbell J.D. | Executive Vice President & Chief Legal Officer |
Ms. Silvana Battaglia | Executive Vice President & Chief Human Resources Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Steven H. Collis | Executive Chairman | Male | 1961 | 5.98M |
Dr. Robert P. Mauch Ph.D., PharmD | President, Chief Executive Officer & Director | 1967 | 3.25M | |
Mr. James F. Cleary Jr. | Executive Vice President & Chief Financial Officer | Male | 1963 | 2.4M |
Ms. Elizabeth S. Campbell J.D. | Executive Vice President & Chief Legal Officer | Female | 1975 | 1.97M |
Ms. Silvana Battaglia | Executive Vice President & Chief Human Resources Officer | Female | 1968 | 1.72M |
Cencora, Inc. Insider Trades
Date | 19 Aug |
Name | COLLIS STEVEN H |
Role | Executive Chairman |
Transaction | Acquired |
Type | M-Exempt |
Shares | 12579 |
Date | 19 Aug |
Name | COLLIS STEVEN H |
Role | Executive Chairman |
Transaction | Disposed |
Type | S-Sale |
Shares | 14579 |
Date | 19 Aug |
Name | COLLIS STEVEN H |
Role | Executive Chairman |
Transaction | Disposed |
Type | M-Exempt |
Shares | 12579 |
Date | 18 Aug |
Name | Mauch Robert P. |
Role | President & CEO |
Transaction | Acquired |
Type | M-Exempt |
Shares | 3225 |
Date | 18 Aug |
Name | Mauch Robert P. |
Role | President & CEO |
Transaction | Disposed |
Type | S-Sale |
Shares | 4968 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
19 Aug | COLLIS STEVEN H | Executive Chairman | Acquired | M-Exempt | 12579 |
19 Aug | COLLIS STEVEN H | Executive Chairman | Disposed | S-Sale | 14579 |
19 Aug | COLLIS STEVEN H | Executive Chairman | Disposed | M-Exempt | 12579 |
18 Aug | Mauch Robert P. | President & CEO | Acquired | M-Exempt | 3225 |
18 Aug | Mauch Robert P. | President & CEO | Disposed | S-Sale | 4968 |